OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ASF1B promotes cervical cancer progression through stabilization of CDK9
Xinjian Liu, Jingwei Song, Yenan Zhang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 678-696
Closed Access | Times Cited: 44

TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3
Qi Zhang, Yong Li, Qing Zhu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 8

Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 42

ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28

Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
Xinyao Hu, Hua Zhu, Xiaoyu Zhang, et al.
Cancer Medicine (2021) Vol. 10, Iss. 19, pp. 6897-6916
Open Access | Times Cited: 34

H3–H4 histone chaperones and cancer
Dominique Ray-Gallet, Geneviève Almouzni
Current Opinion in Genetics & Development (2022) Vol. 73, pp. 101900-101900
Open Access | Times Cited: 27

Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma
Ming‐Rui Du, Jintao Gu, Chenlin Liu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 24

ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
Mengyuan Zhao, Junchang Zhang, Yanjun He, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Nicotiana benthamiana anti-silencing function-1 mediated chromatin modulation during geminivirus infection
Shirin Sultana, Supriya Chakraborty
Physiology and Molecular Biology of Plants (2025)
Closed Access

ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types
Wencheng Zhang, Zhouyong Gao, Mingxiu Guan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 29

Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer
Zhou Zhao, Zhaolun Cai, Su Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216796-216796
Open Access | Times Cited: 4

Effects of Metformin on the virus/host cell crosstalk in human papillomavirus‐positive cancer cells
Karin Hoppe‐Seyler, Anja L. Herrmann, Antonia Däschle, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 5, pp. 1137-1149
Open Access | Times Cited: 23

ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer
Chuanzhi Chen, Haili Bao, Lin Wu, et al.
Journal of Cancer (2022) Vol. 13, Iss. 6, pp. 1985-2000
Open Access | Times Cited: 16

The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β–mediated AML progression
Hsin‐Yun Lin, Mona Mohammadhosseini, John McClatchy, et al.
Blood (2024) Vol. 143, Iss. 26, pp. 2749-2762
Open Access | Times Cited: 3

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
Shirong Zhang, Longwen Xu, Jinteng Feng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14

Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer
Kun Wang, Zhiqiang Hao, Xibo Fu, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 7, pp. 1947-1957
Closed Access | Times Cited: 13

Targeting cyclin-dependent kinase 9 in cancer therapy
Yili Shen, Yanmao Wang, Yaxin Zhang, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 7, pp. 1633-1645
Open Access | Times Cited: 17

Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer
Jae Kim, Yuna Youn, Jong-Chan Lee, et al.
Cancer Biomarkers (2022) Vol. 34, Iss. 4, pp. 647-659
Closed Access | Times Cited: 11

DANCR deletion retards the initiation and progression of hepatocellular carcinoma based on gene knockout and patient-derived xenograft in situ hepatoma mice model
Xiaojie Gan, Dongyang Ding, Mengchao Wang, et al.
Cancer Letters (2022) Vol. 550, pp. 215930-215930
Closed Access | Times Cited: 10

Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer
Marina Dudea-Simon, Dan Mihu, Laura Pop, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6054-6054
Open Access | Times Cited: 9

Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA
Liya Huang, Ting Ye, Jingjing Wang, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top